| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/19/2004 | WO2003060119A3 Method for the quantification of in vivo nucleic acid levels |
| 02/19/2004 | WO2003054218A3 Nucleotide polymorphisms associated with osteoporosis |
| 02/19/2004 | WO2003054016A3 Method for cloning of variable domain sequences |
| 02/19/2004 | WO2003053855A3 Rapid high-throughput screen for detecting biological species in ballast water |
| 02/19/2004 | WO2003050265A3 Compositions and methods for normalizing assays |
| 02/19/2004 | WO2003049683A3 Use of parapox b2l protein to treat cancer and modify immune responses |
| 02/19/2004 | WO2003048780A3 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 02/19/2004 | WO2003048384A3 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms |
| 02/19/2004 | WO2003048193A3 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN |
| 02/19/2004 | WO2003046149A3 Methods of using improved polymerases |
| 02/19/2004 | WO2003045974A3 Methods and compositions for derepression of iap-inhibited caspase |
| 02/19/2004 | WO2003042364A3 Identifying and controlling the growth of estrogen-responsive cells |
| 02/19/2004 | WO2003034072A3 Diagnosis and therapy of conditions involving alms1 |
| 02/19/2004 | WO2003027291A3 Hdv nucleic acid molecules, fragments and applications thereof |
| 02/19/2004 | WO2003025006A3 Purified polypeptides involved in co-factor metabolism |
| 02/19/2004 | WO2003023061A3 Reading, detection or quantification method, hybrids or complexes used in said method and the biochip using same |
| 02/19/2004 | WO2003018770A3 Amplified oncogenes and their involvement in cancer |
| 02/19/2004 | WO2003016564A3 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods |
| 02/19/2004 | WO2003014731A3 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/19/2004 | WO2003008537A9 Epitope sequences |
| 02/19/2004 | WO2003004532A3 Q9ul33/q9nzz4 and q9h5p3 splice variants |
| 02/19/2004 | WO2003000040A3 A nucleic acid-based method for tree phenotype prediction: dna markers for fibre and wood quality properties |
| 02/19/2004 | WO2002094778A3 Peptide conjugates and fluorescence detection methods for intracellular caspase assay |
| 02/19/2004 | WO2002088325A3 Vector system for selection of genes encoding secreted proteins and membrane-bound proteins |
| 02/19/2004 | WO2002088184A9 A molecular marker |
| 02/19/2004 | WO2002083940A3 Screening method for anti-microbial drug targets by genome-saturing mutagenesis (gsm) |
| 02/19/2004 | WO2002083867A3 Ires enabled gene trapping in plants |
| 02/19/2004 | WO2002083866A3 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions |
| 02/19/2004 | WO2002083852A3 Microfermentor device and cell based screening method |
| 02/19/2004 | WO2002077206A9 Compositiona and methods useful for hcv infection |
| 02/19/2004 | WO2002070750A3 Method of determining dihydropyrimidine dehydrogenase gene expression |
| 02/19/2004 | WO2002070732A3 Method for assaying non-spermine/spermidine activity of spermidine/spermine n1acetyltransferase (ssat) |
| 02/19/2004 | WO2002068452B1 Method of isolating charged compounds, especially peptides and proteins |
| 02/19/2004 | WO2002063298A3 Gap junction permeability assay |
| 02/19/2004 | WO2002063037A9 Method for identifying functional nucleic acids |
| 02/19/2004 | WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 02/19/2004 | WO2002059370A3 Methods for identifying compounds that modulate disorders related to nitric oxide/cgmp-dependent protein kinase signaling |
| 02/19/2004 | WO2002057993A3 Method for evaluating conditional probabilities in biotechnology |
| 02/19/2004 | WO2002057566A3 Method for identifying compounds modulating sister chromatid separation |
| 02/19/2004 | WO2002052041A3 5' nuclease nucleic acid amplification assay having an improved internal control |
| 02/19/2004 | WO2002052039A3 Methods for selecting and producing pharmaceutical compounds using a library responsive to transcription factors |
| 02/19/2004 | WO2002048337A3 Secreted human proteins |
| 02/19/2004 | WO2002046477A3 Endogenous retroviruses up-regulated in prostate cancer |
| 02/19/2004 | WO2002046463A3 Nucleic acid extraction method and kit |
| 02/19/2004 | WO2002042328A3 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 02/19/2004 | WO2002038806A3 Detection of nucleic acid polymorphisms |
| 02/19/2004 | WO2002034949A3 Methods for identifying genes associated with diseases or specific phenotypes |
| 02/19/2004 | WO2002032920A3 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 02/19/2004 | WO2002027018A3 Methods for identifying compounds that modulate biofilm activity |
| 02/19/2004 | WO2002006526A8 Detection of copy number changes in colon cancer |
| 02/19/2004 | WO2001088190A3 Poly-primed amplification of nucleic acid sequences |
| 02/19/2004 | WO2000075277A3 A MOLECULAR MARKER BASED ON THE Frk2 (FRUCTOKINASE 2) GENE |
| 02/19/2004 | US20040034890 Identification of soybeans having resistance to Phytophthora sojae |
| 02/19/2004 | US20040034880 Comprises trangenic caenorhabditis elegans mutants associated with constitutive pharyngeal pumping, increased gut permeability and/or altered molecular transport for use as animal model and drug screening tools |
| 02/19/2004 | US20040034211 For DNA, using Denaturing Matched Ion Polynucleotide Chromatography; includes analysis of PCR amplification products to identify factors that affect PCR replication fidelity, design of PCR primers, selection of temperature |
| 02/19/2004 | US20040034207 Crystal structure of antibiotics bound to the 30S ribosome and its use |
| 02/19/2004 | US20040033980 Method of down-regulating gene expression |
| 02/19/2004 | US20040033978 Antisense oligonucleotides complementary to and that hybridize with RNA, used for gene expression inhibition, prophylaxis and medical diagnosis |
| 02/19/2004 | US20040033977 Oligonucleotide modulation of cell adhesion |
| 02/19/2004 | US20040033975 Whole cell engineering using real-time metabolic flux analysis |
| 02/19/2004 | US20040033932 Myc targets |
| 02/19/2004 | US20040033626 Method for gold deposition |
| 02/19/2004 | US20040033602 Using small interfering RNA (siRNA) sequences and polypeptides containing enzymatic domains to control gene expression in cell systems; antisense agents |
| 02/19/2004 | US20040033601 Gene regulatory networks and methods of interdiction for controlling the differentiation state of a cell |
| 02/19/2004 | US20040033595 Conditionally replicating vectors for inhibiting viral infections |
| 02/19/2004 | US20040033587 Method and device for detecting Biologically Active Substances |
| 02/19/2004 | US20040033582 Human single nucleotide polymorphisms |
| 02/19/2004 | US20040033577 Herbicides test method |
| 02/19/2004 | US20040033569 Using site directed mutagenesis to determine and identify physical landscapes associated with protein structure, function and folding |
| 02/19/2004 | US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 02/19/2004 | US20040033563 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 02/19/2004 | US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033555 Applying a plant treatment agent to a substrate, inoculating the substrate with the disease organism, and detecting photon emission from light-generating moieties |
| 02/19/2004 | US20040033552 Preventing off flavor and odors in male swine meat via decreasing expression of glucuronyl transferase, increasing expression of phenol sulfotransferase and enhancing skatole metabolism in swine |
| 02/19/2004 | US20040033551 Assay for low molecular weight heparin |
| 02/19/2004 | US20040033548 Compositions and methods for regulating bacterial pathogenesis |
| 02/19/2004 | US20040033547 Detection of fecal contamination |
| 02/19/2004 | US20040033542 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer |
| 02/19/2004 | US20040033540 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides |
| 02/19/2004 | US20040033534 Using peptide mimetics to prevent binding and gene expression activation by phosphorylated aspartyl regulatory protein; decreasing development of antibiotic resistance in pathogenic bacteria; gene expression inhibition |
| 02/19/2004 | US20040033532 Designing inhibitors of angiotensin-converting enzyme (ACE) for treating cardiovascular, hypertensive, kidney and atherosclerotic disorders |
| 02/19/2004 | US20040033531 Kit which utilizes fluorescent polarization to monitor nucleic acid hybridization |
| 02/19/2004 | US20040033530 High throughput purification, characterization and identification of recombinant proteins |
| 02/19/2004 | US20040033526 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/19/2004 | US20040033525 Releasable nonvolatile mass-label molecules |
| 02/19/2004 | US20040033524 Using presence of restriction fragment length polymorphisms in adrenergic receptors to diagnosis hypertension, eating and cardiovascular disorders and identify individual who may benefit from adrenergic blocking agents |
| 02/19/2004 | US20040033522 Method of DNA sequencing using cleavable tags |
| 02/19/2004 | US20040033520 Diagnosing metastatic colorectal, stomach and/or esophageal cancer in vitro; immunoassay; radioimaging tumors; immunotherapeutics; genetic vaccines |
| 02/19/2004 | US20040033519 Binary or polynary targeting and uses thereof |
| 02/19/2004 | US20040033518 Characterization of single stranded nucleic acids by melting analysis of secondary structure using double strand-specific nucleic acid dye |
| 02/19/2004 | US20040033517 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (PAR1) |
| 02/19/2004 | US20040033516 Diagnosing autoimmune disease via presence or absence of allelic human leukocyte antigen amplification product |
| 02/19/2004 | US20040033513 Method and probes for the genetic diagnosis of hereditary haemocromatosis |
| 02/19/2004 | US20040033510 Using uniform extension and visualization of DNA and/or RNA to detect trisomic chromosomes |
| 02/19/2004 | US20040033507 Multiples sequencing method |
| 02/19/2004 | US20040033503 Method for attaching oligonucleotide to solid support and the oligonucleotide array prepared by the method thereof |
| 02/19/2004 | US20040033502 Diagnosing cancer of the alimentary canal using differentail expression patterns of tumor marker proteins such as apolipoprotein C-1, galectin 4, keratin 18, annexin A10 and cathepsin E |
| 02/19/2004 | US20040033499 Preparing double stranded DNA from messenger RNA using modified/genetically engineered primase; biosynthesis of complimentary nucleotide sequences |